Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2025-01-09 | 2025-01-30 | 247322 |
| TEVA-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2023-11-09 | 2023-12-14 | 209669 |
| TEVA-ATOMOXETINE | 80MG | CAPSULE | Resolved | 2021-09-23 | 2022-03-24 | 146122 |
| TEVA-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2022-08-18 | 2022-10-01 | 167188 |
| TEVA-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2022-09-30 | 2023-01-19 | 170789 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-06-03 | 2022-08-19 | 161949 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-08-18 | 2022-10-18 | 167153 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2022-10-17 | 2023-01-12 | 172013 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-10-28 | 2023-01-12 | 173061 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-11-14 | 2023-01-12 | 174586 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-11-14 | 2023-04-28 | 174589 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118922 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2020-08-13 | 2020-10-08 | 122204 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2020-10-01 | 2020-10-22 | 125461 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2019-09-19 | 2019-10-04 | 94372 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2019-12-05 | 2020-02-07 | 100293 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2020-01-30 | 2020-02-13 | 104884 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177508 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177511 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-12-08 | 2023-02-02 | 177514 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LAMOTRIGINE | 25MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81388 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-04-29 | 2025-04-29 | 256085 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-04-25 | 2025-04-25 | 255824 |
| TEVA-LATANOPROST | 50MCG | SOLUTION | Discontinued | 2020-07-10 | 2020-07-10 | 120009 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81298 |
| TEVA-LISINOPRIL (TYPE P) | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81400 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104257 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Discontinued | 2019-08-15 | 2019-08-15 | 91648 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81301 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 25MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81368 |
| TEVA-LOSARTAN/HCTZ | 50.0MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133902 |
| TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133899 |
| TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133896 |
| TEVA-MEDROXYPROGESTERONE | 10MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256119 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256113 |
| TEVA-MEDROXYPROGESTERONE | 5MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256116 |
| TEVA-METOPROLOL | 50MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119976 |